Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons

IF 4.6 2区 医学 Q1 NEUROSCIENCES
Victoria Mitchell , Bruno G. Frenguelli , Saskia Bakker , Richard T. Ngomba , Magnus Richardson , Emily Hill , Mark J. Wall
{"title":"Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons","authors":"Victoria Mitchell ,&nbsp;Bruno G. Frenguelli ,&nbsp;Saskia Bakker ,&nbsp;Richard T. Ngomba ,&nbsp;Magnus Richardson ,&nbsp;Emily Hill ,&nbsp;Mark J. Wall","doi":"10.1016/j.neuropharm.2025.110455","DOIUrl":null,"url":null,"abstract":"<div><div>Sleep disturbances frequently occur early in dementias such as Alzheimer's disease (AD) and potentially arise from many factors including cortico-thalamo-cortical (CTC) loop dysfunction. It has been reported that tau filament deposition occurs in the thalamus and there is thalamic atrophy in symptomatic AD patients which could contribute to CTC loop disturbance. Here we have investigated whether human recombinant tau soluble aggregates can induce dysfunction in thalamic circuits. Electrophysiological measurements were made from acutely isolated male and female rat corticothalamic slices following incubation with tau aggregates. Tau aggregates markedly reduced the threshold for inducing spindle-like oscillations and increased the excitability of thalamic neurons. Tau aggregates also significantly enhanced the frequency of miniature excitatory postsynaptic currents recorded in ventrobasal thalamic neurons, suggesting possible changes in terminal Ca<sup>2+</sup> influx. These pro-excitatory effects of tau aggregates could contribute to the aberrant CTC loop dysfunction observed in AD models and patients, which manifests as sleep disturbances and absence seizures.</div></div>","PeriodicalId":19139,"journal":{"name":"Neuropharmacology","volume":"273 ","pages":"Article 110455"},"PeriodicalIF":4.6000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0028390825001613","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Sleep disturbances frequently occur early in dementias such as Alzheimer's disease (AD) and potentially arise from many factors including cortico-thalamo-cortical (CTC) loop dysfunction. It has been reported that tau filament deposition occurs in the thalamus and there is thalamic atrophy in symptomatic AD patients which could contribute to CTC loop disturbance. Here we have investigated whether human recombinant tau soluble aggregates can induce dysfunction in thalamic circuits. Electrophysiological measurements were made from acutely isolated male and female rat corticothalamic slices following incubation with tau aggregates. Tau aggregates markedly reduced the threshold for inducing spindle-like oscillations and increased the excitability of thalamic neurons. Tau aggregates also significantly enhanced the frequency of miniature excitatory postsynaptic currents recorded in ventrobasal thalamic neurons, suggesting possible changes in terminal Ca2+ influx. These pro-excitatory effects of tau aggregates could contribute to the aberrant CTC loop dysfunction observed in AD models and patients, which manifests as sleep disturbances and absence seizures.
可溶性tau聚集物降低丘脑振荡的阈值,增加丘脑神经元的兴奋性。
睡眠障碍经常发生在老年痴呆症(如阿尔茨海默病(AD))的早期,并且可能由许多因素引起,包括皮质-丘脑-皮层(CTC)回路功能障碍。有报道称,症状性AD患者的丘脑中存在tau丝沉积和丘脑萎缩,这可能导致CTC回路紊乱。在这里,我们研究了人类重组tau可溶性聚集体是否可以诱导丘脑回路功能障碍。电生理测量是在急性分离的雄性和雌性大鼠皮质丘脑切片与tau聚集体孵育后进行的。Tau聚集体显著降低了诱导梭状振荡的阈值,增加了丘脑神经元的兴奋性。Tau聚集体还显著增强了腹基底丘脑神经元中记录的微型兴奋性突触后电流的频率,表明终端Ca2+内流可能发生变化。这些tau聚集体的促兴奋作用可能导致在AD模型和患者中观察到的CTC环异常功能障碍,其表现为睡眠障碍和失神发作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuropharmacology
Neuropharmacology 医学-神经科学
CiteScore
10.00
自引率
4.30%
发文量
288
审稿时长
45 days
期刊介绍: Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信